Cancer of the uterine cervix is susceptible to anti-EGF-R antibody EMD 55,900 therapy

Anticancer Research

Volumn 25, Issue 6 B, 2005, Pages 4261-4267

  Solbach, Christine ^a   Roller, Marc ^a   Nicoletti, Maria ^a   Budischewski, Kai ^a   Knecht, Rainald ^a   Kaufmann, Manfred ^a  

^a GOETHE UNIVERSITY   (Germany)

Author keywords

Angiogenesis; Cancer; CD 31; Cervix; EMD 55,900

Indexed keywords

EMD 55900; EMD 55900 ANTIBODY; EPIDERMAL GROWTH FACTOR RECEPTOR ANTIBODY; MONOCLONAL ANTIBODY; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ANTIBODY DETECTION; ARTICLE; CELL DENSITY; CONTROLLED STUDY; DRUG POTENCY; FEMALE; HUMAN; HUMAN TISSUE; IN VIVO STUDY; MICROVASCULATURE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; UTERINE CERVIX CARCINOMA; XENOTRANSPLANTATION;

ANIMALS; ANTIBODIES, MONOCLONAL; FEMALE; HUMANS; IMMUNIZATION, PASSIVE; IMMUNOGLOBULIN G; MICE; RECEPTOR, EPIDERMAL GROWTH FACTOR; UTERINE CERVICAL NEOPLASMS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 27944493514     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Ciardiello F and Tortora G: Epidermal growth factor receptor (EGFR) as a target in cancer therapy: understanding the role of receptor expression and other molecular determinants that could influence the response to anti-EGFR drugs. Eur J Cancer 39(10): 1348-1354, 2003.
2. Mendelsohn J and Baselga J: The EGF receptor family as targets for cancer therapy. Oncogene 19: 6550-6565, 2000.
3. Mendelsohn J and Baselga J: Status of epidermal growth factor receptor antagonists in the biology and treatment of cancer. J Clin Oncol 21(14): 2787-2799, 2003.
4. Bier H, Hoffmann T, Haas I and van Lierop A: Anti-(epidermal growth factor) receptor monoclonal antibodies for the induction of antibody-dependent cell-mediated cytotoxicity against squamous cell carcinoma lines of the head and neck. Cancer Immunol Immunother 46(3): 167-173, 1998.
5. Solbach C, Sterner-Kock A, Roller M, Schnurch HG, Stegmuller M, Caspar-Bell G, Schumm-Draeger PM, Kaufmann M and Knecht R: Antitumor effect of MAb EMD 55900 depends on EGF-R expression and histopathology. Neoplasia 4(3): 237-242, 2002.
6. Ciardiello F, Caputo R, Bianco R, Damiano V, Fontanini E, Cuccato S, De Placido S, Bianco AR and Tortora G: Inhibition of growth factor production and angiogenesis in human cancer cells by ZD1839 (Iressa), a selective epidermal growth factor receptor tyrosine kinase inhibitor. Clin Cancer Res 7: 1459-1465, 2001.
7. Perrotte P, Matsumoto T, Inoue K, Kuniyasu H, Eve BY, Hicklin DJ, Radinsky R and Dinney CPN: Anti-epidermal growth factor receptor antibody C225 inhibits angiogenesis in human transitional cell carcinoma growing ortotopically in nude mice. Clin Cancer Res 5: 257-264, 1999.
8. Solbach C, Roller M, Ahr A, Loibl S, Nicoletti M, Stegmueller M, Kreysch HG, Knecht R and Kaufmann M: Anti-epidermal growth factor receptor-antibody therapy for treatment of breast cancer. Int J Cancer 101(4): 390-394, 2002.
9. Solbach C, Roller M, Budischewski K, Loibl S, Nicoletti M, Stegmueller M and Kaufmann M: EGF-R and Her2/neu overexpressing tumours: independent collectives for treatment of breast cancer by specific monoclonal antibody therapy. J Cancer Res Clin Oncol 129(4): 250-251, 2003.
10. Murthy U, Basu U, Rodeck U, Herlyn M, Ross AH and Das M: Binding of an antagonistic monoclonal antibody to an intact and fragmented EGF-receptor polypeptide. Arch Biochem Biophys 252: 549-560, 1987.
11. Kiernann JA: Histological and Histochemical Methods: Theory and Practice. 2nd ed., Pergamon Press, Oxford, 1990.
12. Wu X, Rubin M, Fan Z, DeBlasio T, Soos T, Koff A and Mendelsohn J: Involvement of p27KIP1 in G1 arrest mediated by an anti-epidermal growth factor receptor monoclonal antibody. Oncogene 12(7): 1397-1403, 1996.
13. Ben-Bassat H, Rosenbaum-Mitrani S, Hartzstark Z, Shlomai Z, Kleinberger-Doron N, Gazit A, Plowman G, Levitzki R, Tsvieli R and Levitzki A: Inhibitors of epidermal growth factor receptor kinase and of cyclin-dependent kinase 2 activation induce growth arrest, differentiation, and apoptosis of human papilloma virus 16-immortalized human keratinocytes. Cancer Res 57(77): 3741-3750, 1997.
14. Ciardiello F, Caputo R, Damiano V, Caputo R, Troiani T, Vitagliano D, Carlomagno F, Veneziani BM, Fontanini G, Bianco AR and Tortora G: Antitumour effects of ZD6474, a small molecule vascular endothelial growth factor receptor tyrosine kinase inhibitor, with additional activity against epidermal growth factor receptor tyrosine kinase. Clin Cancer Res 9(4): 1546-1556, 2003.
15. Jung YD, Mansfield PF, Akagi M, Takeda A, Liu W, Bucana CD, Hicklin DJ and Ellis LM: Effects of combination antivascular endothelial growth factor receptor and anti-epidermal growth factor receptor therapies on the growth of gastric cancer in a nude mouse model. Eur J Cancer 38(8): 1133-1140, 2002.